To measure the expression levels of LMP1 and LMP2 in NPC-positive cells (C666-1 and CNE-2Z) and NPC-negative cells (HNE-2), quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting assays were performed. This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.